Thus, our findings implicate the necessity to consider the NMD pathway when examining the regulation of p53 β isoforms, for example, in tumors, given that aberrant p53β expression8–14,40,41 and dysfunctional NMD12,22–24 are both observed in human cancers. The gene discussed is IGFBP3; the disease is cancer.